v3.25.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain
Accumulated Deficit 
Series Seed Preferred Stock
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Temporary equity, beginning balance (in shares) at Dec. 31, 2023           3,963,963 5,704,161 11,370,621 0
Temporary equity, beginning balance at Dec. 31, 2023           $ 13,014 $ 25,235 $ 110,791 $ 0
Convertible Preferred Stock                  
Issuance of Series C Preferred Stock, net of issuance costs (in shares)                 18,628,970
Issuance of Series C Preferred Stock, net of issuance costs                 $ 181,328
Temporary equity, ending balance (in shares) at Dec. 31, 2024           3,963,963 5,704,161 11,370,621 18,628,970
Temporary equity, ending balance at Dec. 31, 2024 $ 330,368         $ 13,014 $ 25,235 $ 110,791 $ 181,328
Beginning balance (in shares) at Dec. 31, 2023   3,050,863              
Beginning balance at Dec. 31, 2023 (114,881) $ 2 $ 4,515 $ 0 $ (119,398)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock from IPR&D acquisition (in shares)   1,414,445              
Issuance of common stock from IPR&D acquisition 8,639 $ 2 8,637            
Exercise of common stock options (in shares)   71,264              
Exercise of common stock options 141 $ 1 140            
Vesting of restricted common stock awards (in shares)   186,191              
Vesting of restricted common stock awards 0                
Stock-based compensation expense 3,708   3,708            
Unrealized gain on marketable debt securities 368     368          
Net loss $ (61,688)       (61,688)        
Ending balance (in shares) at Dec. 31, 2024 4,722,763 4,722,763              
Ending balance at Dec. 31, 2024 $ (163,713) $ 5 17,000 368 (181,086)        
Convertible Preferred Stock                  
Conversion of convertible preferred stock into common stock (in shares)           (3,963,963) (5,704,161) (11,370,621) (18,628,970)
Conversion of convertible preferred stock to common stock upon closing of initial public offering           $ (13,014) $ (25,235) $ (110,791) $ (181,328)
Temporary equity, ending balance (in shares) at Dec. 31, 2025 0         0 0 0 0
Temporary equity, ending balance at Dec. 31, 2025 $ 0         $ 0 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)   27,149,206              
Conversion of convertible preferred stock to common stock upon closing of initial public offering 330,367 $ 27 330,340            
Issuance of common stock from initial public offering, net of issuance costs (in shares)   12,176,467              
Issuance of common stock from initial public offering, net of issuance costs $ 199,570 $ 12 199,558            
Exercise of common stock options (in shares) 599,191 599,191              
Exercise of common stock options $ 3,639 $ 1 3,638            
Vesting of restricted common stock awards (in shares)   75,958              
Vesting of restricted common stock awards 0                
Stock-based compensation expense 12,066   12,066            
Unrealized gain on marketable debt securities 172     172          
Net loss $ (75,268)       (75,268)        
Ending balance (in shares) at Dec. 31, 2025 44,723,585 44,723,585              
Ending balance at Dec. 31, 2025 $ 306,833 $ 45 $ 562,602 $ 540 $ (256,354)